UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of
Report (Date of earliest event reported): Ferbuary 17,
2010
REMEDENT,
INC.
(Exact
name of registrant as specified in its charter)
Nevada
(State
or Other Jurisdiction of
Incorporation)
|
|
001-15975
(Commission
File Number)
|
|
86-0837251
(IRS
Employer
Identification
No.)
|
Xavier de Cocklaan 42,
9831, Deurle, Belgium
(Address
of Principal Executive Offices)
|
|
N/A
(Zip
Code)
|
011-329-321-70-80
(Registrant's
telephone number, including area code)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below):
o
|
Written communications pursuant
to Rule 425 under the Securities Act (17 CFR
230.425)
|
o
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
o
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
o
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
Section 2 – Financial
Information
Item
2.02 Results of Operations and Financial Condition.
On February 17, 2010, the Company
issued a press release reporting its financial results for the fiscal third
quarter ended December 31, 2009, and announcing a conference call to discuss the
results on Thursday, February 18, 2010.
A copy of the press release is attached
hereto as Exhibit 99.1 and incorporated herein by
reference.
Section 7 –
Regulation FD
Item
7.01. Regulation FD Disclosure
On February 17, 2010, the
Company issued a press release reporting its
financial
results for the fiscal third quarter ended December 31, 2009, and
announcing the launch of its new corporate website and a conference
call to discuss the financial results on Thursday, February 18,
2010.
A copy of the press release is attached
hereto as Exhibit 99.1 and incorporated herein by reference.
Section 9 – Financial
Statements and Exhibits
Item
9.01 Financial Statements and Exhibits.
(d)
Exhibits
.
Exhibit
No.
|
Exhibit
Description
|
99.1
|
Press
Release dated February 17, 2010
|
The
information set forth under Items 2.02 and 7.01 of this Form 8-K and Exhibit
99.1attached hereto are furnished and shall not be deemed “filed” for purposes
of Section 18 of the Securities Exchange Act of 1934, and shall not be deemed
incorporated by reference in any filing with the Securities and Exchange
Commission under the Securities Exchange Act of 1934 or the Securities Act of
1933, whether made before or after the date hereof and irrespective of any
general incorporation by reference language in any filing.
Portions
of this report constitute “forward-looking statements” defined by federal
law. Although the Company believes any such statements are based on
reasonable assumptions, there is no assurance that the actual outcomes will not
be materially different. Any such statements are made in reliance on the “safe
harbor” protections provided under the Private Securities Litigation Reform Act
of 1995. Additional information about issues that could lead to material changes
in the Company’s performance is contained in the Company’s filings with the
Securities and Exchange Commission and may be accessed at
www.sec.gov.
SIGNATURE
Pursuant to the requirements of the
Securities Exchange Act of 1934, the registrant has duly caused this report to
be signed on its behalf by the undersigned hereunto duly
authorized.
|
REMEDENT,
INC.,
|
|
|
a
Nevada corporation
|
|
|
|
|
|
|
|
|
|
|
|
Dated: February
17, 2010
|
|
By:
|
/s/ Stephen Ross
|
|
|
|
|
Stephen Ross
|
|
|
|
|
Chief Financial Officer
|
|